156 related articles for article (PubMed ID: 35363373)
1. Venous-thromboembolism and associated health care utilization in elderly patients with diffuse large B cell lymphoma.
Gangaraju R; Davis ES; Bhatia S; Kenzik KM
Cancer; 2022 Jun; 128(12):2348-2357. PubMed ID: 35363373
[TBL] [Abstract][Full Text] [Related]
2. Incidence of venous thromboembolism and predictive ability of age-adjusted international prognostic index for prediction of venous thromboembolism in Asian patients with diffuse large B-cell lymphoma.
Hantrakun N; Phinyo P; Tantiworawit A; Rattarittamrong E; Chai-Adisaksopha C; Rattanathammethee T; Hantrakool S; Piriyakhuntorn P; Punnachet T; Niprapan P; Norasetthada L
J Thromb Thrombolysis; 2024 Mar; 57(3):473-482. PubMed ID: 38091158
[TBL] [Abstract][Full Text] [Related]
3. Impact of diffuse large B-cell lymphoma on visits to different provider specialties among elderly Medicare beneficiaries: challenges for care coordination.
Garg R; Sambamoorthi U; Tan X; Basu SK; Haggerty T; Kelly KM
Transl Behav Med; 2018 May; 8(3):386-399. PubMed ID: 29370438
[TBL] [Abstract][Full Text] [Related]
4. Incidence of venous thromboembolism in patients with non-Hodgkin lymphoma.
Sanfilippo KM; Wang TF; Gage BF; Luo S; Riedell P; Carson KR
Thromb Res; 2016 Jul; 143():86-90. PubMed ID: 27208462
[TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factors for developing venous thromboembolism in Japanese with diffuse large b-cell lymphoma.
Yokoyama K; Murata M; Ikeda Y; Okamoto S
Thromb Res; 2012 Jul; 130(1):7-11. PubMed ID: 22000981
[TBL] [Abstract][Full Text] [Related]
6. Incidence of venous thromboembolism in patients with diffuse large B-cell lymphoma.
Borg IH; Bendtsen MD; Bøgsted M; Madsen J; Severinsen MT
Leuk Lymphoma; 2016 Dec; 57(12):2771-2776. PubMed ID: 27266904
[TBL] [Abstract][Full Text] [Related]
7. Mean platelet volume as a predictive marker for venous thromboembolism and mortality in patients treated for diffuse large B-cell lymphoma.
Rupa-Matysek J; Gil L; Kroll-Balcerzak R; Barańska M; Komarnicki M
Hematol Oncol; 2017 Dec; 35(4):456-464. PubMed ID: 27377517
[TBL] [Abstract][Full Text] [Related]
8. Cross-sectional Study of Patients with Diffuse Large B-Cell Lymphoma: Assessing the Effect of Host Status, Tumor Burden, and Inflammatory Activity on Venous Thromboembolism.
Lim SH; Woo SY; Kim S; Ko YH; Kim WS; Kim SJ
Cancer Res Treat; 2016 Jan; 48(1):312-21. PubMed ID: 25761485
[TBL] [Abstract][Full Text] [Related]
9. The Application of the ThroLy Risk Assessment Model to Predict Venous Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma.
Abdel-Razeq H; Ma'koseh M; Mansour A; Bater R; Amarin R; Abufara A; Halahleh K; Manassra M; Alrwashdeh M; Almomani M; Zmaily M
Clin Appl Thromb Hemost; 2021; 27():10760296211045908. PubMed ID: 34590497
[TBL] [Abstract][Full Text] [Related]
10. Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma.
Upshaw JN; Nelson J; Rodday AM; Kumar AJ; Klein AK; Konstam MA; Wong JB; Jaffe IZ; Ky B; Friedberg JW; Maurer M; Kent DM; Parsons SK
JAMA Cardiol; 2023 May; 8(5):453-461. PubMed ID: 36988926
[TBL] [Abstract][Full Text] [Related]
11. Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score.
Rupa-Matysek J; Gil L; Kaźmierczak M; Barańska M; Komarnicki M
Med Oncol; 2017 Dec; 35(1):5. PubMed ID: 29209847
[TBL] [Abstract][Full Text] [Related]
12. Impact of venous thromboembolism on mortality of elderly Medicare patients with stage III colon cancer.
Hanna N; Bikov KA; McNally D; Onwudiwe NC; Dalal M; Mullins CD
Oncologist; 2012; 17(9):1191-7. PubMed ID: 22767876
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and Predictors of Palliative Care Utilization among Hospitalized Patients with Diffuse Large B-Cell Lymphoma.
Jackson I; Etuk A; Jackson N
J Palliat Care; 2023 Apr; 38(2):167-174. PubMed ID: 35006019
[No Abstract] [Full Text] [Related]
14. Mental health disorders and survival among older patients with diffuse large B-cell lymphoma in the USA: a population-based study.
Kuczmarski TM; Tramontano AC; Mozessohn L; LaCasce AS; Roemer L; Abel GA; Odejide OO
Lancet Haematol; 2023 Jul; 10(7):e530-e538. PubMed ID: 37271158
[TBL] [Abstract][Full Text] [Related]
15. Oncologist volume and outcomes in older adults diagnosed with diffuse large B cell lymphoma.
Huntington SF; Hoag JR; Zhu W; Wang R; Zeidan AM; Giri S; Podoltsev NA; Gore SD; Ma X; Gross CP; Davidoff AJ
Cancer; 2018 Nov; 124(21):4211-4220. PubMed ID: 30216436
[TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolism in patients with diffuse large B-cell lymphoma.
Komrokji RS; Uppal NP; Khorana AA; Lyman GH; Kaplan KL; Fisher RI; Francis CW
Leuk Lymphoma; 2006 Jun; 47(6):1029-33. PubMed ID: 16840193
[TBL] [Abstract][Full Text] [Related]
17. Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL).
Griffiths R; Gleeson M; Knopf K; Danese M
BMC Cancer; 2010 Nov; 10():625. PubMed ID: 21073707
[TBL] [Abstract][Full Text] [Related]
18. Safety, effectiveness, and health care cost comparisons among elderly patients with venous thromboembolism prescribed warfarin or apixaban in the United States Medicare population.
Hlavacek P; Guo JD; Rosenblatt L; Keshishian A; Russ C; Mardekian J; Ferri M; Poretta T; Yuce H; McBane R
Curr Med Res Opin; 2019 Dec; 35(12):2043-2051. PubMed ID: 31387467
[No Abstract] [Full Text] [Related]
19. Healthcare utilization and spending among older patients diagnosed with Non-Hodgkin lymphoma.
Kenzik KM; Williams GR; Bhakta N; Robison LL; Landier W; Goyal G; Mehta A; Bhatia S
J Geriatr Oncol; 2021 Nov; 12(8):1225-1232. PubMed ID: 34176753
[TBL] [Abstract][Full Text] [Related]
20. Treatment patterns and comparative effectiveness in elderly diffuse large B-cell lymphoma patients: a surveillance, epidemiology, and end results-medicare analysis.
Hamlin PA; Satram-Hoang S; Reyes C; Hoang KQ; Guduru SR; Skettino S
Oncologist; 2014 Dec; 19(12):1249-57. PubMed ID: 25342313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]